Drugs / Quinvaxem
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 33 trials | ||||||
| Phase 3 | NCT01917357 | Sep 2013 → Apr 2014 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +1 | Crucell Holland BV | Completed | No outcome recorded |
| Phase 3 | NCT01470287 | Dec 2011 → Apr 2012 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +1 | Novartis Vaccines | Completed | No outcome recorded |
| Phase 3 | NCT01362517 | Apr → Jul 2010 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +1 | Crucell Holland BV | Completed | No outcome recorded |
| Phase 41 trial · 1 met primary | ||||||
| Phase 4 | NCT01357720 | May → Sep 2011 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +1 | Crucell Holland BV | Completed | Met primary |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02408926 Comparator | Apr 2015 → Aug 2018 | pertussis | University of Antwerp | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2013-05-09 | Institute of Vaccines and Medical Biologicals, Vietnam | Regulatory Việt Nam tạm ngừng sử dụng vắc xin 5 trong 1 Quinvaxem com.vn ↗
Ngày 4/5, Bộ Y tế thông báo trên toàn quốc về việc tạm ngừng ngay việc sử dụng vắc xin Quinvaxem inj trong dự án tiêm chủng mở rộng. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2013-05-09 | Institute of Vaccines and Medical Biologicals, Vietnam | Việt Nam tạm ngừng sử dụng vắc xin 5 trong 1 Quinvaxem com.vn ↗ |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quinvaxem | “The ready-to-use, preservative free, fully-liquid combination DTwP-HepB-Hib vaccine, Quinvaxem(®), offers convenience of administering five important vaccine antigens to...” PMID 23783081 ↗ Jun 2013 |
| Known as | DTwP-HepB-Hib | “Assessment of the Immunogenicity and Safety of Quinvaxem Vaccine (DTwP-HepB-Hib) Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by H. Influenzae Among...” NCT01362517 ↗ |
| Modality | Vaccine | “Quinvaxem, a fully-liquid, pentavalent combination vaccine containing inactivated hepatitis B (HepB), Haemophilus influenzae type b (Hib) and whole-cell pertussis (wP)...” PMID 24176498 ↗ Oct 2013 |
| Route | Intramuscular | “One dose of Quinvaxem given intramuscularly at Weeks 6, 10 and 14” NCT01917357 ↗ |